144 related articles for article (PubMed ID: 21272158)
21. Sensitization of endothelial cells to VEGI-induced apoptosis by inhibiting the NF-kappaB pathway.
Grimaldo S; Tian F; Li LY
Apoptosis; 2009 Jun; 14(6):788-95. PubMed ID: 19418226
[TBL] [Abstract][Full Text] [Related]
22. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
[TBL] [Abstract][Full Text] [Related]
23. Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene products.
Kunnumakkara AB; Diagaradjane P; Guha S; Deorukhkar A; Shentu S; Aggarwal BB; Krishnan S
Clin Cancer Res; 2008 Apr; 14(7):2128-36. PubMed ID: 18381954
[TBL] [Abstract][Full Text] [Related]
24. Targeting colon cancer stem cells using a new curcumin analogue, GO-Y030.
Lin L; Liu Y; Li H; Li PK; Fuchs J; Shibata H; Iwabuchi Y; Lin J
Br J Cancer; 2011 Jul; 105(2):212-20. PubMed ID: 21694723
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of the NF-κB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties.
Olivera A; Moore TW; Hu F; Brown AP; Sun A; Liotta DC; Snyder JP; Yoon Y; Shim H; Marcus AI; Miller AH; Pace TW
Int Immunopharmacol; 2012 Feb; 12(2):368-77. PubMed ID: 22197802
[TBL] [Abstract][Full Text] [Related]
26. Pectenotoxin-2 abolishes constitutively activated NF-kappaB, leading to suppression of NF-kappaB related gene products and potentiation of apoptosis.
Kim MO; Moon DO; Heo MS; Lee JD; Jung JH; Kim SK; Choi YH; Kim GY
Cancer Lett; 2008 Nov; 271(1):25-33. PubMed ID: 18602210
[TBL] [Abstract][Full Text] [Related]
27. Curcumin dually inhibits both mammalian target of rapamycin and nuclear factor-κB pathways through a crossed phosphatidylinositol 3-kinase/Akt/IκB kinase complex signaling axis in adenoid cystic carcinoma.
Sun ZJ; Chen G; Zhang W; Hu X; Liu Y; Zhou Q; Zhu LX; Zhao YF
Mol Pharmacol; 2011 Jan; 79(1):106-18. PubMed ID: 20959361
[TBL] [Abstract][Full Text] [Related]
28. Newly synthesized curcumin analog has improved potential to prevent colorectal carcinogenesis in vivo.
Shibata H; Yamakoshi H; Sato A; Ohori H; Kakudo Y; Kudo C; Takahashi Y; Watanabe M; Takano H; Ishioka C; Noda T; Iwabuchi Y
Cancer Sci; 2009 May; 100(5):956-60. PubMed ID: 19445025
[TBL] [Abstract][Full Text] [Related]
29. Activation of PI3K/Akt/IKK-alpha/NF-kappaB signaling pathway is required for the apoptosis-evasion in human salivary adenoid cystic carcinoma: its inhibition by quercetin.
Sun ZJ; Chen G; Hu X; Zhang W; Liu Y; Zhu LX; Zhou Q; Zhao YF
Apoptosis; 2010 Jul; 15(7):850-63. PubMed ID: 20386985
[TBL] [Abstract][Full Text] [Related]
30. Curcumin analogue GO-Y030 inhibits STAT3 activity and cell growth in breast and pancreatic carcinomas.
Hutzen B; Friedman L; Sobo M; Lin L; Cen L; De Angelis S; Yamakoshi H; Shibata H; Iwabuchi Y; Lin J
Int J Oncol; 2009 Oct; 35(4):867-72. PubMed ID: 19724924
[TBL] [Abstract][Full Text] [Related]
31. W346 inhibits cell growth, invasion, induces cycle arrest and potentiates apoptosis in human gastric cancer cells in vitro through the NF-κB signaling pathway.
Xia Y; Weng B; Wang Z; Kang Y; Shi L; Huang G; Ying S; Du X; Chen Q; Jin R; Wu J; Liang G
Tumour Biol; 2016 Apr; 37(4):4791-801. PubMed ID: 26520440
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, and biological evaluation of novel
Xie X; Tu J; You H; Hu B
Drug Des Devel Ther; 2017; 11():1439-1451. PubMed ID: 28553074
[TBL] [Abstract][Full Text] [Related]
33. Targeting the NF-κB and mTOR pathways with a quinoxaline urea analog that inhibits IKKβ for pancreas cancer therapy.
Radhakrishnan P; Bryant VC; Blowers EC; Rajule RN; Gautam N; Anwar MM; Mohr AM; Grandgenett PM; Bunt SK; Arnst JL; Lele SM; Alnouti Y; Hollingsworth MA; Natarajan A
Clin Cancer Res; 2013 Apr; 19(8):2025-35. PubMed ID: 23444213
[TBL] [Abstract][Full Text] [Related]
34. The Curcumin Analog GO-Y030 Controls the Generation and Stability of Regulatory T Cells.
MaruYama T; Kobayashi S; Nakatsukasa H; Moritoki Y; Taguchi D; Sunagawa Y; Morimoto T; Asao A; Jin W; Owada Y; Ishii N; Iwabuchi Y; Yoshimura A; Chen W; Shibata H
Front Immunol; 2021; 12():687669. PubMed ID: 34248973
[TBL] [Abstract][Full Text] [Related]
35. The effect of the NF-kappa B inhibitors curcumin and lactacystin on myogenic differentiation of rhabdomyosarcoma cells.
Berger F; Büchsler I; Munz B
Differentiation; 2012 Jun; 83(5):271-81. PubMed ID: 22469857
[TBL] [Abstract][Full Text] [Related]
36. Structure-Activity Relationships of the Antitumor C5-Curcuminoid GO-Y030.
Kohyama A; Yamakoshi H; Hongo S; Kanoh N; Shibata H; Iwabuchi Y
Molecules; 2015 Aug; 20(8):15374-91. PubMed ID: 26305242
[TBL] [Abstract][Full Text] [Related]
37. Da0324, an inhibitor of nuclear factor-κB activation, demonstrates selective antitumor activity on human gastric cancer cells.
Jin R; Xia Y; Chen Q; Li W; Chen D; Ye H; Zhao C; Du X; Shi D; Wu J; Liang G
Drug Des Devel Ther; 2016; 10():979-95. PubMed ID: 27042000
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of IkappaB kinase-nuclear factor-kappaB signaling pathway by 3,5-bis(2-flurobenzylidene)piperidin-4-one (EF24), a novel monoketone analog of curcumin.
Kasinski AL; Du Y; Thomas SL; Zhao J; Sun SY; Khuri FR; Wang CY; Shoji M; Sun A; Snyder JP; Liotta D; Fu H
Mol Pharmacol; 2008 Sep; 74(3):654-61. PubMed ID: 18577686
[TBL] [Abstract][Full Text] [Related]
39. Curcumin induces cell-arrest and apoptosis in association with the inhibition of constitutively active NF-kappaB and STAT3 pathways in Hodgkin's lymphoma cells.
Mackenzie GG; Queisser N; Wolfson ML; Fraga CG; Adamo AM; Oteiza PI
Int J Cancer; 2008 Jul; 123(1):56-65. PubMed ID: 18386790
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of 86 species of 1,5-diaryl-3-oxo-1,4-pentadienes analogs of curcumin can yield a good lead in vivo.
Kudo C; Yamakoshi H; Sato A; Nanjo H; Ohori H; Ishioka C; Iwabuchi Y; Shibata H
BMC Pharmacol; 2011 May; 11():4. PubMed ID: 21619659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
